Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Venus Medtech (Hangzhou) Inc.
  6. Summary
    2500   CNE100003PJ8

VENUS MEDTECH (HANGZHOU) INC.

(2500)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
07/21/2021 07/22/2021 07/23/2021 07/26/2021 07/27/2021 Date
60.15 59.1 57.75 49.25 45.1 Last
868000 1132926 1793500 2662500 7406534 Volume
+0.84% -1.75% -2.28% -14.72% -8.43% Change
Estimated financial data (e)
Sales 2021 621 M 95,5 M 95,5 M
Net income 2021 49,9 M 7,66 M 7,66 M
Net cash position 2021 2 505 M 385 M 385 M
P/E ratio 2021 472x
Yield 2021 -
Sales 2022 1 168 M 179 M 179 M
Net income 2022 288 M 44,3 M 44,3 M
Net cash position 2022 2 353 M 362 M 362 M
P/E ratio 2022 56,6x
Yield 2022 -
Capitalization 16 638 M 2 555 M 2 557 M
EV / Sales 2021 22,7x
EV / Sales 2022 12,2x
Nbr of Employees 509
Free-Float 70,5%
More Financials
Company
Venus MedTech (HangZhou) Inc. is a China-based company engaged in the research, development, manufacture and sales of minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The Company's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8 / TAV8 and... 
More about the company
Ratings of Venus Medtech (Hangzhou) Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about VENUS MEDTECH (HANGZHOU) INC.
07/27VENUS MEDTECH HANGZHOU : Appoints Professor Martin B. Leon as Global Principal I..
AQ
07/27VENUS MEDTECH HANGZHOU : Appoints Professor Martin B. Leon as Global Principal I..
PR
07/26VENUS MEDTECH HANGZHOU : Voluntary announcement unaudited operating statistics f..
PU
07/26Venus Medtech Inc. Announces Unaudited Group Revenue Results for the Six Mont..
CI
06/30Venus Medtech Inc. Announces Formation of Joint Venture Company with Healium ..
CI
05/06VENUS MEDTECH HANGZHOU : Voluntary announcement latest investment project
PU
05/05VENUS MEDTECH HANGZHOU : Invests in Medical Device Manufacturer
MT
05/05Hangzhou Valgen Medtech Technology Co., Ltd. announced that it has received $..
CI
04/20VENUS MEDTECH HANGZHOU : Proxy form for use at the 2021 first class meeting of h..
PU
04/20VENUS MEDTECH HANGZHOU : Proxy form for use at the 2021 first class meeting of h..
PU
04/20VENUS MEDTECH HANGZHOU : Notice of 2021 first class meeting of holders of unlist..
PU
04/20VENUS MEDTECH HANGZHOU : Notice of 2021 first class meeting of holders of h shar..
PU
04/06VENUS MEDTECH HANGZHOU : Trims Loss in 2020 as Revenue Soars 18%
MT
03/31Venus Medtech Inc. Announces Change of Principal Place of Business in Hong Ko..
CI
03/31Venus Medtech Inc. Announces Audited Consolidated Earnings Results for the Ye..
CI
More news
News in other languages on VENUS MEDTECH (HANGZHOU) INC.

- No features available -

More news
Chart VENUS MEDTECH (HANGZHOU) INC.
Duration : Period :
Venus Medtech (Hangzhou) Inc. Technical Analysis Chart | 2500 | CNE100003PJ8 | MarketScreener
Technical analysis trends VENUS MEDTECH (HANGZHOU) INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 37,73 CNY
Average target price 72,33 CNY
Spread / Average Target 91,7%
EPS Revisions
Managers and Directors
Zhen Jun Zi Executive Director & General Manager
Haiyue Ma Chief Financial Officer & Joint Secretary
Min Zeng Chairman
Yan Xiao Chairman-Supervisory Board
Hou-Sen Lim Executive Director, COO & Chief Technology Officer
Sector and Competitors